Genevant Sciences
Genevant brings world-class delivery platforms that include best-in-class lipid nanoparticle (LNP) technology and next generation ligand conjugate technology, the industry’s most robust and expansive LNP patent estate, decades of experience and expertise in nucleic acid drug development.
Date, time and room information
May 5, 14:45 - 15:00, room Montreal
Category
Clinical stage development company
Title of the presentation
Innovating Delivery of Next-Generation Nucleic Acid Therapetics
Speaker information
| Name | Position | Institution |
|---|---|---|
| Ed Yaworski | Chief Technology Officer | Genevant Sciences |
